Skip to main content

Table 2 IC50 values (nM) of cetuximab treatment in three HNSCC cell lines (mean ± standard deviation)

From: The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines

Cell line Normoxia 24 h hypoxia 72 h hypoxia
LICR-HN2 0.08 ± 0.03 0.12 ± 0.05 0.08 ± 0.08
LICR-HN5 0.42 ± 0.10 0.37 ± 0.09 1.17 ± 0.47
SC263 2.38 ± 0.59 0.64 ± 0.38 0.10 ± 0.05